Ledger.Open graph →
SEC Form D · filed June 8, 2017

FENNEC PHARMACEUTICALS INC

Offering
$7.6M
Sold
$7.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Chris Rallis · Research Triangle Park, NCDirectorAdrian Haigh · Research Triangle Park, NCDirectorSteven Skolsky · RESEARCH TRIANGLE PARK, NCDirectorKrysia Lynes · RESEARCH TRIANGLE PARK, NCExecRostislav Raykov · Research Triangle Park, NCExec · DirectorKhalid Islam · Research Triangle Park, NCDirectorAdrian Haigh · Research Triangle Park, NCDirectorSteven Skolsky · Research Triangle Park, NCDirectorChris Rallis · Mission Viejo, CADirectorKrysia Lynes · Research Triangle Park, NCExecRostislav Raykov · Research Triangle Park, NCExec · DirectorKhalid Islam · Research Triangle Park, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗